Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies

Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies

Background/Aims: Emerging studies have shown that the neutrophil-lymphocyte ratio (NLR) is a potential predictor in various tumors. Our study was conducted to assess the prognostic value of the pretreatment NLR in bladder cancer and metastatic or unresectable urothelial carcinoma (mUC or uUC) patien...

Full description

Bibliographic Details
Main Authors:	Shuiqing Wu, Xiaokun Zhao, Yinhuai Wang, Zhaohui Zhong, Lei Zhang, Jian Cao, Kai Ai, Ran Xu
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2018-04-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Bladder cancer Metastatic unresectable urothelial carcinoma Unresectable urothelial carcinoma Neutrophil-Lymphocyte ratio Prognosis
Online Access:	https://www.karger.com/Article/FullText/489152

Similar Items

Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
by: Hiroyuki Nishiyama, et al.
Published: (2023-06-01)

Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data
by: Fischer C, et al.
Published: (2020-06-01)

Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma
by: Wael Abdo Hassan, et al.
Published: (2023-03-01)

Negative Effects of Stromal Neutrophils on T Cells Reduce Survival in Resectable Urothelial Carcinoma of the Bladder
by: Meihua Yang, et al.
Published: (2022-03-01)

Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab
by: Xiao Y, et al.
Published: (2023-11-01)

Lymphoepithelioma-Like Carcinoma of Urinary Bladder with Diagnostic Dilemma: Case Report of a Rare Variant of Urothelial Carcinoma
by: Swati Saini, et al.
Published: (2022-03-01)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
by: Hong-Chen Qu, et al.
Published: (2020-01-01)

The value of plasma osteopontin levels as a predictive factor of disease stage and recurrence in patients with bladder urothelial carcinoma: A prospective study
by: Min-Gu Park, et al.
Published: (2012-10-01)

Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas
by: Ezgi HACIHASANOĞLU, et al.
Published: (2021-01-01)

Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
by: Fateme Khalatbari, et al.
Published: (2023-09-01)

Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma
by: Zhen-Peng Cao, et al.
Published: (2017-01-01)

The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma
by: Risa Tomioka-Inagawa, et al.
Published: (2022-07-01)

Orbital Metastasis from Urothelial Carcinoma of the Urinary Bladder
by: Han-Ching Lin, et al.
Published: (2007-02-01)

Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer
by: Itamar Getzler, et al.
Published: (2018-10-01)

Fine needle aspiration cytology of metastatic urothelial carcinoma: Study of seven cases with review of literature
by: Gagandeep Kaur, et al.
Published: (2012-01-01)

A case of acute lymphocytic gastritis related to treatment with pembrolizumab for metastatic urothelial carcinoma
by: Yousuke Fukiishi, et al.
Published: (2023-03-01)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
by: Dong Chen, et al.
Published: (2021-12-01)

Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice
by: Félix Lefort, et al.
Published: (2023-11-01)

Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma
by: Kyotaro Fukuta, et al.
Published: (2022-03-01)

Nested variant of urothelial carcinoma of the urinary bladder
by: Tadashi Terada
Published: (2011-12-01)

FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?
by: Iason Psilopatis, et al.
Published: (2023-01-01)

Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma
by: I-Hung Shao, et al.
Published: (2016-04-01)

Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)

Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis
by: Felix Riedel, et al.
Published: (2022-06-01)

Advanced Bladder Cancer: Changing the Treatment Landscape
by: Vladimir Bilim, et al.
Published: (2022-10-01)

Synchronous primary tumors of the bladder: Successfully managed case
by: Farah Boutaggount, MD, et al.
Published: (2022-10-01)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
by: Christina Therkildsen, et al.
Published: (2018-08-01)

Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
by: Rehab Mohamed Sharaf, et al.
Published: (2022-09-01)

Association between Age and Histopathological Grade of Bladder Urothelial Carcinoma
by: Dionisius Alby, et al.
Published: (2017-12-01)

Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients
by: Yu J, et al.
Published: (2018-12-01)

Systemic Immunotherapy for Urothelial Cancer: Current Trends and Future Directions
by: Shilpa Gupta, et al.
Published: (2017-01-01)

Diagnosis and management of intradiverticular bladder tumours: A pooled analysis of 498 cases
by: Stamatios Katsimperis, et al.
Published: (2022-12-01)

Complete Response to Enfortumab Vedotin in a Hemodialysis Patient with Metastatic Urothelial Carcinoma: A Case Report
by: Bunpei Isoda, et al.
Published: (2023-06-01)

A Study on Association of Urine Cytology as Reported by the Paris System with Histopathology and p53 Expression in Urinary Bladder Epithelial Neoplasms
by: Soumitra Das, et al.
Published: (2019-10-01)

Sixth Cranial Nerve Palsy and Craniocervical Junction Instability due to Metastatic Urothelial Bladder Carcinoma
by: Davide Nasi, et al.
Published: (2019-01-01)

From Conversion to Resection for Unresectable Hepatocellular Carcinoma: A Review of the Latest Strategies
by: Chen Liang, et al.
Published: (2023-12-01)

Clinicopathological profile of urothelial carcinoma of the bladder: A five-year retrospective study
by: Syifa Ul Izzah, et al.
Published: (2023-09-01)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
by: Rui Zhu, et al.
Published: (2019-10-01)

Non-urothelial and urothelial variants of bladder cancer
by: Eun-mi Yu, et al.
Published: (2022-01-01)

Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy
by: Bahareh Farasati Far, et al.
Published: (2023-03-01)